He took vitamin D for two years. His level barely moved.

Persona

Carlos, 44, Male, Latin American, Architect.

He has taken 2,000 IU of vitamin D every day for two years, but his latest level is still 19 ng/mL. He feels tired, his mood dips in winter, and he wants to know why the number will not move.

Family history: Father: osteoporosis diagnosed at age 68.

Clinical picture

Symptoms

• Persistent fatigue, worse in winter
• Low mood in winter months
• No muscle weakness or bone pain currently

Labs

• Vitamin D (25-OHD): 19 ng/mL (20–50 ng/mL)
• Bone density (lumbar spine): T-score −1.3 (T-score above −1.0)

Medications

• No prescription medications

Supplements

• Vitamin D3 2,000 IU daily (two years)

Lifestyle

• Office-based work, limited outdoor time
• Diet: varied, not high in oily fish or fortified foods
• Non-smoker, alcohol occasional

Genetics

• VDR Taq1 (Reduced-sensitivity variant): Carlos's cells may need a higher vitamin D level than average before they get the same signal.
• GC rs4588 / rs7041 (Reduced binding protein function): His blood test may make his vitamin D status look better than it feels inside his cells, because less may be freely available to use.
• CYP2R1 rs10741657 (Reduced-function variant): Carlos may swallow the supplement, but his liver converts less of it into the storage form measured on the blood test.

Two years. Every day. Still low.

Carlos's family doctor flagged low vitamin D at a routine check two years ago. The advice was simple: take 2,000 IU daily. He did it consistently, every morning with breakfast. At the next annual test, his level was still below range. The answer was to take more, but nobody explained why the first plan had barely worked. Carlos started to wonder what the blood test was missing.

What the vitamin D test misses

The standard vitamin D test measures the storage form in the blood. It does not show how much is free to reach cells, how well the body converted the supplement, or how strongly the cells respond. For many people, the total number is a useful guide. For Carlos, the same number may mean less usable vitamin D than it would for someone else.

His cells need a stronger signal

Carlos may need a higher blood level to get the same effect inside his cells. His VDR result suggests the vitamin D receptor is less responsive than average, so a low-normal result may still act low for him. The reference range is built around population averages. Carlos is not average on this pathway.

The supplement had two more hurdles

The receptor result explains why his target may need to be higher. The GC and CYP2R1 results explain why getting there has been hard. One affects how much vitamin D is freely available to cells. The other affects how much of the supplement becomes 25-OHD, the form measured on his lab report. He was not failing the plan. The plan was running into three bottlenecks at once.

Five things to discuss with his clinician

• Discuss a higher target, not just getting above the lower cutoff. His VDR result means the same blood level may not create the same cell signal.
• Adjust the dose only with clinician supervision and recheck in about 3 months. Monitoring keeps the plan effective and helps avoid sustained high-dose risk.
• Ask about magnesium alongside vitamin D. Magnesium supports vitamin D activation, including the CYP2R1 step that may already be slower for him.
• Ask whether vitamin K2 (MK-7) makes sense with D3. Given his family history of osteoporosis and borderline bone density, calcium direction is part of the conversation.
• Ask whether a free vitamin D test is available. It measures the unbound fraction, which is the part most relevant to his GC result.

Why standard dosing missed Carlos

The blood number did not tell the whole story. This shows how far his functional vitamin D may sit below his effective target, and which changes help close the gap. The dial is not a disease risk score. Gap from optimal for his VDR variant (on 2,000 IU) baseline 68%.

• Clinician-guided higher dose: A higher dose can help offset lower CYP2R1 activation efficiency, because more input can still produce more converted vitamin D.
• Add magnesium support: Magnesium is required for CYP2R1 to function. His low-normal level may add another bottleneck to the activation step.
• Vitamin K2 for bone support: K2 helps direct absorbed calcium toward bone, which is relevant given his osteopenia finding and family history of osteoporosis.
• Consistent daily timing (with a meal): Vitamin D is fat-soluble. Taking it with the largest meal of the day improves absorption by 30–50% compared to taking it fasted — a simple change that compounds over months.